The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis

Background and Objectives: Iron deficiency and anemia characterize patients on chronic hemodialysis (HD). Available intravenous iron agents, such as ferric gluconate (FG) and ferric carboxymaltose (FCM), vary in dosing regimens and safety profiles. The aim of the present study was to analyze the mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacquaniti, Antonio, Gargano, Romana, Campo, Susanna, Casuscelli di Tocco, Teresa, Schifilliti, Silvia, Monardo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305135/
https://www.ncbi.nlm.nih.gov/pubmed/37374275
http://dx.doi.org/10.3390/medicina59061071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305135/
https://www.ncbi.nlm.nih.gov/pubmed/37374275
http://dx.doi.org/10.3390/medicina59061071

Ejemplares similares